Monitoring platelet function in people with subdural hematoma taking aspirin
Treatments studied
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This study checks how well your platelets are working while you take aspirin for a subdural hematoma. It may help doctors understand how to manage your treatment better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You are being treated for a subdural hematoma (bleeding on the brain's surface).
- You are currently taking aspirin, at any dose.
- You are not taking other blood thinners (like warfarin or DOACs) or other antiplatelet drugs.
- You are not pregnant or breastfeeding, and you agree to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether people with a chronic subdural hematoma (a slow bleed on the brain) who are not having surgery should keep taking aspirin or stop it. It aims to find out which approach is safer and helps the hematoma heal better.
This study looks at the risks of bleeding during and after brain aneurysm surgery for people who take daily low-dose aspirin compared to those who don't. It aims to help doctors make safer decisions about aspirin use before surgery.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
This trial is collecting blood from healthy adults to establish a new reference range for a standard platelet function test. You may be eligible if you do not have any bleeding disorders, are not taking blood thinners or anti-inflammatory medications, and meet other lab criteria.
This trial studies whether starting aspirin early is safe and helpful for people who, after clot-busting treatment for an ischemic stroke, develop a specific type of small brain bleeding called hemorrhagic infarction. You might benefit if your scan later shows this pattern of bleeding and you are not able to take blood-thinners or aspirin is safe for you.
This trial tests whether taking a lower-dose aspirin (81 mg) works as well as a higher-dose aspirin (325 mg) to prevent stroke after a blunt injury that affects blood vessels in the neck/head. It may help some patients lower their stroke risk with the simplest, safest dose.
Hear when a new Hematoma, Subdural trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.